The point I am trying to make is that there is interest in the DC VAX platform by BP. The reason that there has not been a BO, JV, partnership, etc. may be that LP's asking price is too high, at least for now without unblinded results confirmation.
I am not averring that LP is positioning the company for sale or partnership. Accordingly, it makes no difference on what exchange NWBO is on. If NWBO has a platform that is a game changer, there will be demand by BP. The exchange NWBO is traded on is not an impediment to interest which a BP may have. If an offer is not to LP's liking, she won't take it and go it alone.
Bottom-line, if the DC VAX platform engenders a new paradigm in how GBM, indeed solid cancers and other disease in general, will be treated, everybody is interested and the market will have no choice but to ultimately recognise it. Some institutions are prescient and recognise value much sooner than their peers and break ranks. Regardless of whether there is a bidding war or on what exchange NWBO finds itself, a paradigm changing platform will naturally and ultimately rise to its value. LP is patient and can wait for the market to come to such an understanding even if other investors are frustrated by the wait. Insofar as LP and LG are concerned, NWBO is not just an investment vehicle. It is the culmination of their life's work. They want to make their mark and leave a legacy no matter how long it takes and what challenges they encounter. In so many words this is what Les has said in past conversations with me and I believe in his sincerity. As an investor, however, I prefer sooner rather than later.
